Charles River Laboratories International : Proxy Supplement Filed April 24, 2024

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


SCHEDULE 14A



...

Related Keywords

United States ,Charles River ,Massachusetts ,Cambodia ,Vietnam ,Republic Of ,Canada ,Mauritius ,Washington ,Jamesc Foster ,Martin Mackay ,Exchange Act ,Charles River Laboratories International Inc ,Drug Administration ,Exchange Commission ,Office For Responsible Animal Usage ,Centers For Disease ,Company Annual Meeting Of Shareholders ,Company Committed To ,Securities Exchange ,Company Proposal ,Animal Use Committee ,Nhps The Company ,Statement Pursuant ,Securities Exchange Act ,Commission Only ,Specified In Its Charter ,Filing Proxy Statement ,Filing Fee ,Exchange Act Rules ,Charles River Laboratories International ,Annual Meeting ,Proxy Statement ,Proposal Four ,Exceeds What ,Safety Assessment ,Risk Management Process ,Disease Control ,Management Oversight ,Responsible Animal Use Committee ,Responsible Animal Usage ,Proposal Request ,Engagement Informed Content ,Corporate Citizenship Report ,Lead Director ,Corporate Secretary ,Charles River Board ,Glass Lewis ,Global Animal Welfare ,Responsible Animal Use ,New Alternative Methods ,Alternative Methods Advancement Project ,Chief Executive Officer ,Markets ,